riltrava aerosphere
astrazeneca ab - budesonide, formoterol fumarate dihydrate, glycopyrronium bromide - plaušu slimība, hroniska obstruktīva - zāles obstruktīvu elpceļu slimību, - riltrava aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2 agonist or combination of a long-acting beta2 agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5.
dexamethasone krka 20 mg tabletes
krka, d.d., novo mesto, slovenia - deksametazons - tablete - 20 mg
dermovate 0,5 mg/g krēms
glaxosmithkline (ireland) limited, ireland - klobetazola propionāts - krēms - 0,5 mg/g
dermovate 0,5 mg/g krēms
glaxosmithkline (ireland) limited, ireland - klobetazola propionāts - krēms - 0,5 mg/g
dermovate 0,5 mg/g ziede
glaxosmithkline (ireland) limited, ireland - klobetazola propionāts - ziede - 0,5 mg/g
ximluci
stada arzneimittel ag - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmoloģiskie līdzekļi - ximluci is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).
ranivisio
midas pharma gmbh - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmoloģiskie līdzekļi - ranivisio is indicated in adults for:• the treatment of neovascular (wet) age-related macular degeneration (amd)• the treatment of visual impairment due to diabetic macular oedema (dme)• the treatment of proliferative diabetic retinopathy (pdr)• the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)• the treatment of visual impairment due to choroidal neovascularisation (cnv).
dermovate 0,5 mg/g ziede
glaxosmithkline (ireland) limited, ireland - klobetazola propionāts - ziede - 0,5 mg/g
tadalafil zentiva 20 mg apvalkotās tabletes
zentiva, k.s., czech republic - tadalafils - apvalkotā tablete - 20 mg
tadalafil stada 10 mg apvalkotās tabletes
stada arzneimittel ag, germany - tadalafils - apvalkotā tablete - 10 mg